Atrion Corporation

ATRI

US0499041053

Medical Equipment, Supplies & Distribution

Real-time Estimate Cboe BZX Other stock markets 03:15:42 2024-04-25 pm EDT			5-day change	1st Jan Change
394.6 ^USD	-6.97%		+3.34%	+5.22%

Apr. 09	Atrion Corporation Announces Not Stand for Re-Election of Hugh J. Morgan, Jr. as Member of Board	CI
Feb. 29	Atrion Corporation Reports Earnings Results for the Full Year Ended December 31, 2023	CI

ATRION CORP : Results of Operations and Financial Condition, Financial Statements and Exhibits (form 8-K)

August 06, 2020 at 05:02 pm EDT

Item 2.02. Results of Operations and Financial Condition.

On August 6, 2020, the Registrant issued a press release, a copy of which is attached hereto as Exhibit 99.1 and is incorporated herein by reference.

Item 9.01. Financial Statements and Exhibits.





  Exhibit 99.1        Press Release dated August 6, 2020
Exhibit 104         Cover Page Interactive Data File (embedded within the Inline
                    XBRL document)

Latest news about Atrion Corporation

Atrion Corporation Announces Not Stand for Re-Election of Hugh J. Morgan, Jr. as Member of Board	Apr. 09	CI
Atrion Corporation Reports Earnings Results for the Full Year Ended December 31, 2023	Feb. 29	CI
Earnings Flash (ATRI) ATRION CORPORATION Reports Q4 Revenue $43.6M	Feb. 29	MT
Earnings Flash (ATRI) ATRION CORPORATION Posts Q4 EPS $3.65	Feb. 29	MT
Atrion Corporation Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	Feb. 29	CI
Atrion Keeps Quarterly Cash Dividend at $2.20 Per Share, Payable on March 29 to Shareholders of Record on March 15	Feb. 27	MT
Atrion Corporation Declares Quarterly Cash Dividend, Payable on March 29, 2024	Feb. 27	CI
North American Morning Briefing : S&P 500 Futures Ease From Nvidia-Inspired Record High	Feb. 23	DJ
Atrion Corporation Enters into an Amended and Restated Credit Agreement	Dec. 28	CI
Atrion Maintains Quarterly Dividend at $2.20 a Share, Payable Dec. 15 to Shareholders of Record on Dec. 1	Nov. 13	MT
Atrion Corporation Declares Quarterly Cash Dividend, Payable on December 15, 2023	Nov. 13	CI
Tranche Update on Atrion Corporation's Equity Buyback Plan announced on May 22, 2015.	Nov. 07	CI
Atrion Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 07	CI
Earnings Flash (ATRI) ATRION CORPORATION Posts Q3 Revenue $41.9M	Nov. 07	MT
Atrion Corporation Announces Election of Jeannette Bankes as Director	23-09-20	CI
Atrion Increases Dividend to $2.20 a Share From $2.15, Payable on Sept. 29 to Shareholders as of Sept. 15	23-08-22	MT
Tranche Update on Atrion Corporation's Equity Buyback Plan announced on May 22, 2015.	23-08-08	CI
Earnings Flash (ATRI) ATRION CORPORATION Posts Q2 Revenue $43.8M	23-08-08	MT
Earnings Flash (ATRI) ATRION CORPORATION Posts Q2 EPS $3.73	23-08-08	MT
Atrion Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-08	CI
Atrion Retains Quarterly Dividend of $2.15 a Share, Payable June 30 to Shareholders of Record on June 15	23-05-23	MT
Atrion Corporation Declares Quarterly Dividend, Payable on June 30, 2023	23-05-23	CI
Tranche Update on Atrion Corporation's Equity Buyback Plan announced on May 22, 2015.	23-05-08	CI
Earnings Flash (ATRI) ATRION CORPORATION Posts Q1 Revenue $40M	23-05-08	MT
Atrion Corporation Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-08	CI

Atrion Corporation develops and manufactures products, primarily for medical applications. The Company's medical products are used in a number of fields including fluid delivery, cardiovascular, and ophthalmic applications. It has developed a variety of proprietary valves designed to precisely fill, hold, and release and/or remove controlled amounts of fluids, including blood and drugs, or gasses on demand for use in areas such as intubation, intravenous, catheter, and other applications in fields including anesthesia and oncology. The core of its cardiovascular products is its Myocardial Protection System, a technology that is the only open-heart surgery system that delivers to the heart essential fluids and medications, mixes critical drugs, and controls temperature, pressure, and other important variables. The Company also manufactures a line of balloon catheters used in the treatment of nasolacrimal duct obstruction in children and adults.

Sector

Medical Equipment, Supplies & Distribution

Calendar

2024-05-05 - Q1 2024 Earnings Release (Projected)

Related indices

Russell 2000

More about the company

Income Statement Evolution

More financial data

Sector Other Medical Equipment, Supplies & Distribution

	1st Jan change	Capi.
ATRION CORPORATION	+5.22%	747M
ABBOTT LABORATORIES	-3.00%	185B
MEDTRONIC PLC	-3.82%	107B
BECTON, DICKINSON AND COMPANY	-5.33%	67.55B
DEXCOM, INC.	+11.21%	54.6B
CENCORA, INC.	+16.54%	47.42B
HOYA CORPORATION	+3.86%	42.24B
WEST PHARMACEUTICAL SERVICES, INC.	+5.75%	28.24B
METTLER-TOLEDO INTERNATIONAL, INC.	+1.53%	26.42B
TERUMO CORPORATION	+12.40%	25.66B